Arnon Rosenthal
About Arnon Rosenthal
Arnon Rosenthal's Role at Annexon Biosciences
Arnon Rosenthal is the Co-Founder, Chief Executive Officer, and Director at Annexon Biosciences, Inc. He played a crucial role in the establishment and early leadership of the company, serving as its acting Chief Executive Officer from August 2011 to December 2014. His leadership and strategic direction were instrumental in guiding the initial phases of the company.
Educational Background of Arnon Rosenthal
Arnon Rosenthal holds a Ph.D. in biology from the Hebrew University of Jerusalem. His profound understanding of biology and extensive research experience underpin his professional achievements and contributions to the biotechnology industry.
Arnon Rosenthal's Contributions to Migraine Treatment
Arnon Rosenthal co-founded Rinat Neuroscience Corporation, which was pivotal in the discovery and development of the migraine drug Ajovy. This drug represents a significant advancement in migraine treatment and highlights Rosenthal's impact on neuropharmaceutical developments.
Career at Genentech: Discoveries by Arnon Rosenthal
Arnon Rosenthal's career at Genentech, Inc. spanned from January 1985 to August 2001. During this time, he served as a Staff Scientist and a permanent member of Genentech's Research Review Committee. Rosenthal's team identified the target for the cancer drug Erivedge, contributing to advancements in cancer treatment. He also conducted his post-doctoral fellowship at Genentech, showcasing his long-term commitment and contributions to the company.